The Lancet Respiratory Medicine · 2018 · 93 citations · 42 references
PharmacyImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyImmunotherapy SafetyPulmonary ToxicityPulmonary Toxicity ManagementPulmonary ToxicologyToxicity ManagementCancer Therapy-related Pulmonary ToxicityImmunotherapy-related PneumonitisPulmonary Toxic InjuryPulmonary Toxicity GradingPulmonary Toxicity Mechanisms
42
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael Kalos, David M. Barrett et al. · New England Journal of Medicine · 2013 · 3.5K citations · Full text